In a big week for the marijuana industry and a surprise to most of the industry, Senators Schumer (D-NY), (Murray D-WA), Wyden (D-OR), Cory Booker (D-NJ) and 14 others have deduced to follow the public and make a change. As of today, Senate leadership pushes end of federal prohibition of cannabis.
Senator Patty Murray, a senior member and former Chair of the Senate Committee on Health, Education, Labor, and Pensions (HELP) has long been a champion of veterans. This falls in line with PTSD treatments and with the American Medical Association’s backing of rescheduling and more medical research to see how the cannabis plant can help more patients.
They have reintroduced the Cannabis Administration and Opportunity Act (CAOA), legislation that would end the harmful federal prohibition of cannabis by removing cannabis from the list of federally controlled substances and empowering states to create their own laws. This legislation would be a historic step toward rectifying the failed policies of the War on Drugs and would help federal law better reflect the will of the vast majority of Americans, 91% of whom believe that cannabis should be legalized for either adult or medical use.
“It is far past time that the federal government catch up to Washington state when it comes to cannabis laws. This legislation is about bringing cannabis regulations into the 21st century with common-sense reforms to promote public safety and public health, and undo deeply unjust laws that have for decades disproportionally harmed people of color,” said Senator Murray. “The Cannabis Administration and Opportunity Act will help set us on a safe and responsible pathway to legalization—I’ll keep working to secure the necessary support to get it done.”
The Cannabis Administration and Opportunity Act establishes a federal regulatory framework to protect public health and safety, prioritizes restorative and economic justice to help undo harm caused by the War on Drugs, ends discrimination in the provision of federal benefits on the basis of cannabis use, provides major investments for cannabis research, and strengthens worker protections. By decriminalizing cannabis at the federal level, the CAOA also ensures that state-legal cannabis businesses or those in adjacent industries will no longer be denied access to bank accounts or financial services simply because of their ties to cannabis.
The Cannabis Administration and Opportunity Act:
Protects public healthby:
Establishing a Center for Cannabis Products to regulate production, labeling, distribution, sales and other manufacturing and retail elements of the cannabis industry.
Instructing the FDA to establish standards for labeling of cannabis products, including potency, doses, servings, place of manufacture, and directions for use.
Establishing programs and funding to prevent youth cannabis use.
Increasing funding for comprehensive opioid, stimulant, and substance use disorder treatment.
Protects public safetyby:
Removing cannabis from the Controlled Substances Act and eliminating federal prohibitions in states that have chosen to legalize medical cannabis, or adult-use cannabis.
Retaining federal prohibitions on trafficking of cannabis in violation of state law; establishing a grant program to help departments combat black market cannabis.
Requiring the Department of Transportation (DOT) to create standards for cannabis-impaired driving.
Directing the National Highway Traffic Safety Administration (NHTSA) to collect data on cannabis-impaired driving, create educational materials on “best practices,” and carry out media campaigns.
Incentivizing states to adopt cannabis open container prohibitions.
Regulates and taxes cannabisby:
Transferring federal jurisdiction over cannabis to the Alcohol and Tobacco Tax and Trade Bureau (TTB).
Eliminating the tax code’s restriction on cannabis businesses claiming deductions for business expenses, and implementing an excise tax on cannabis products.
Establishing market competition rules meant to protect independent producers, wholesalers, and retailers and prevent anti-competitive behavior.
Encourages cannabis research by:
Requiring the Government Accountability Office (GAO) to study and report on metrics that may be impacted by cannabis legalization.
Requiring the Department of Health and Human Services (HHS) and National Institutes of Health (NIH) to conduct or support research on the impacts of cannabis.
Requiring the VA to carry out a series of clinical trials studying the effects of medical cannabis on the health outcomes of veterans diagnosed with chronic pain and post-traumatic stress disorder.
Requiring the Bureau of Labor Statistics to regularly compile and publicize data on the demographics of business owners and employees in the cannabis industry.
Establishing grants to build up cannabis research capacity at institutions of higher education, with a particular focus on minority-serving institutions and Historically Black Colleges and Universities.
Prioritizes restorative and economic justiceby:
Using federal tax revenue to fund an Opportunity Trust Fund to reinvest in communities and individuals most harmed by the failed War on Drugs.
Establishing a Cannabis Justice Office at the Department of Justice’s Office of Justice Programs
Establishing a grant program to provide funding to help minimize barriers to cannabis licensing and employment for individuals adversely impacted by the War on Drugs.
Establishing expedited FDA review of drugs containing cannabis manufactured by small businesses owned by socially and economically disadvantaged individuals.
Directing the Secretary of Housing and Urban Development to establish a grant program to provide communities whose residents have been disproportionately affected by the War on Drugs with additional funding to address the housing, economic, and community development needs of such residents.
Initiating automatic expungement of federal non-violent cannabis offenses and allows an individual currently serving time in federal prison for nonviolent cannabis offense to petition a court for resentencing.
Disallowing the denial of any benefits or protections under immigration law to any noncitizen based on their use or possession of cannabis.
Prevents discrimination in the provision of federal benefits against people who use cannabis.
Strengthens workers’ rights by:
Removing unnecessary federal employee pre-employment and random drug testing for cannabis
Ensuring worker protections for those employed in the cannabis industry.
Establishing grants for community-based education, outreach, and enforcement of workers’ rights in the cannabis industry.
The Cannabis Administration and Opportunity Act is co-sponsored by U.S. Senators Jeff Merkley (D-OR), Kirsten Gillibrand (D-NY), Elizabeth Warren (D-MA), Ed Markey (D-MA), Michael Bennet (D-CO), Gary Peters (D-MI), Tina Smith (D-MN), John Hickenlooper (D-CO), Ben Ray Luján (D-NM), Alex Padilla (D-CA), Peter Welch (D-VT), Rev. Raphael Warnock (D-GA), John Fetterman (D-PA), and Laphonza Butler (D-CA).
Senator Murray has been a leader on common-sense cannabis reforms. She helped introduce the Cannabis Administration and Opportunity Act last Congress, and in 2017, she first introduced the Secure and Fair Enforcement (SAFE) Banking Act which would allow state-legal cannabis businesses to access banking services. She has reintroduced the bill multiple times and is pushing hard for its passage. An updated version of the legislation—the Safe and Fair Enforcement Regulation (SAFER) Banking Act of 2023, which Murray also cosponsored—passed through committee after a bipartisan markup last fall.
The cannabis industry is concerned about the direction of regulations – and the DEA is still against the plant.
The cannabis industry is very concerned for the future. While many supported the incoming president with hopes for action, things look rough. The Speaker of the House is against legal marijuana, the pro-weed Attorney General nominee seems to be in trouble, and some of the new Senate leadership feel cannabis issues as dead on arrival. And is this giving an indicator to the Drug Enforcement Administration (DEA) to not do anything? It is the DEA against the vast majority of the public about marijuana.
Every poll shows at least 88% of the population is for some form of legal cannabis. Florida had almost 57% of their voting public support full recreation. Almost all major medical organizing including the federal government’s Health and Human Services and the Food and Drug Administration, the American Medical Association and the American College of Physicians have supported rescheduling. Their reason is proven science around it providing clear medical benefits. But the DEA seems to be against it.
Now, the DEA and their Chief Administrative Law Judge John Mulrooney has denied a key group from being part of the hearing. Cannabis has been proven to help with PTSD and the Veterans adminstartion has rearranged its process to allow veterans to seek this option of treatment. The Veterans Action Council (VAC), an organization supporting cannabis access for military veterans, petitioned request “status as an interested party” to give testimony.
This is a follow up from an earlier requested to participate. Despite working with the government, the group was not included on the list of 25 participants released Oct. 31 by DEA Administrator Anne Milgram.
According to a footnote in the order denying the Veteran group a chance to testify, the DEA could allow more participants to testify. But DEA DIrector Milgam has shown no love for cannabis or the industry, and the current list leans heavily into the anti-cannabis group and against the general public.
As reported in early summer, Director Milgram made an unusual request of top deputies summoned in March for the “Marijuana Meeting”: Nobody could take notes. This has made the industry very anxious and hoping for a positive outcome for the thousands of mom and pop businesses.
The holidays are also a very busy time of year. And despite the myth, marijuana can help you be more productive.
It is the time of year when you still have a job, but are expected to do extra for all the holidays. Family gatherings, meeting up with friends, shopping, kids concerts and more suddenly jam the schedule. For some, it is the most stressful time of the year. But here is how to be more productive during the holidays with marijuana. Alcohol can often add to the holiday stress by having a hangover or generally making you sluggish.
There is the new trend of California sober, where you swamp marijuana for alcohol and it is taking off. Microdosing (usually with gummies), is another way people are benefiting from the plant without being fully stoned. While smoking is still a popular way to consume, edibles, gummies, vapes and oils are discreet and easy to take into almost any situation.
Also, pay attention to how different strains and consumption methods affect your productivity. Everyone’s endocannabinoid system is unique, so what works for others may not work for you. Experiment responsibly and adjust your approach based on your personal experiences.
Selecting an appropriate cannabis strain is crucial for maintaining productivity. Sativa-dominant strains are generally better suited for daytime use and staying active, as they tend to provide more energizing and uplifting effects. Look for strains high in limonene, a terpene known for its mood-boosting and focus-enhancing properties.
Proper dosing is essential to avoid becoming overly intoxicated. Start with a small amount and gradually increase as needed. Microdosing, which involves consuming very small quantities of cannabis, can be an effective way to experience the benefits without compromising cognitive function.
Before consuming cannabis, take time to establish clear objectives for your day or work session. Writing a to-do list can help declutter your mind and provide a tangible roadmap for your tasks. This practice allows you to focus on execution rather than planning once the effects of marijuana set in.
Consider when and where you use cannabis to maximize its potential benefits. Some users find that consuming during a lunch break or after completing a portion of their work helps refresh their mind without derailing productivity
Once you’ve consumed cannabis, dive straight into your tasks and maintain that momentum throughout your session. Avoid the temptation to take early breaks or rewards, as this can disrupt your flow and make it challenging to regain focus.
Some users find that combining cannabis with moderate amounts of caffeine can help counteract any drowsiness and enhance focus. However, be mindful of your caffeine intake, as excessive consumption may lead to increased anxiety.
Remember that while cannabis can potentially enhance productivity, it’s not a magic solution. Maintain discipline in your consumption habits and work ethic. Start with small amounts, use the momentum to accomplish tasks, and avoid overindulging. By implementing these strategies, you can harness the potential benefits of marijuana while staying productive and focused on your goals. Remember to always consume responsibly and in compliance with local laws and regulations.
Tobacco has long been an economic giant…but is cannabis upending the system?
From the Marlboro Man to Virginia Slims, smoking a cigarette has been iconic. Movie stars, Santa Clause and more encouraged their favorite brands. Soldiers in war received complimentary cigarettes as part of their rations. But when Fred Levine won the famous tobacco lawsuit, the industry reign as a top dog rapidly started to diminish. But can little cannabis help big tobacco? Marijuana has recently surpassed tobacco in popularity among Americans. Currently, 16% of adults report smoking marijuana, compared to only 11% who smoke cigarettes. The power tobacco industry could expand but increase their stake in cannabis.
In the United States and Canada, cigarette consumption peaked in 1965 at a staggering 4,259 cigarettes per capita annually. During this period, about 50% of men and 33% of women smoked regularly. The tobacco industry’s influence extended far beyond sales, shaping culture, advertising, and even medical opinions. “Big Tobacco” includes Philip Morris (now Altria), R.J. Reynolds, British American Tobacco, and Imperial Tobacco were and are key international corporations and used to be big players on the stock market.
A key concern is the change in demographics. Nearly a third of respondents under 35 say they smoke marijuana compared to 8% of young Americans smoke cigarettes at least once a week. A drastic trend which will be hard to change. Gen Z has always drifted away from alcohol and started the California sober movement where they only consume marijuana and don’t drink. The alcohol industry has a stake with over $12 billion invested.
While not at the same level, Big Tobacco seems a future in the plant. Altria Group, the parent company of Philip Morris USA, made one of the largest investments by acquiring a 45% stake in Canadian cannabis company Cronos Group for $1.8 billion. British American Tobacco (BAT) has also been actively investing in cannabis. Imperial and Phillip Morris have shown interest but have yet to make a major play.
Big Tobacco has the clout, cash and cleverness to take marijuana to the next level in not only the US but around the globe. They can make cannabis an international juggernaut not only recreationally, but medically.